 |
|
|
|||||
Roche is set to acquire 89bio for up to $3.5 billion, gaining access to the promising liver disease drug pegozafermin. This move complements Roche's recent forays into the weight-loss market, reflecting a broader strategy to address metabolic diseases. The acquisition underscores Roche's commitment to therapies for cardiovascular, renal, and metabolic conditions.
Category:
News and Media
Nestlé, the global food giant, is undergoing significant changes. New CEO Philipp Navratil is tasked with reviving the company's performance. This follows leadership turmoil and a scandal involving the former CEO. Chairman Paul Bulcke has also retired earlier than planned. The company grapples with falling share prices and strategic missteps.
Category:
News and Media
Urban Company's shares have soared, exceeding expectations after a blockbuster IPO, reaching a 69% gain over the issue price. While analysts suggest booking partial profits, they also highlight the company's strong market position and growth potential. The company recently turned profitable with a net profit of Rs 240 crore in FY25, further fueling investor interest.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||